Skip to content

effect of general anesthesia and spinal anesthesia in percutaneous nephrolithotripsy

Comparison of blood loss volume in patient with Percutaneous nephrolithotripsy between spinal & general anesthesia. lithotripsy

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT201101175632N1
Enrollment
80
Registered
2011-09-01
Start date
2010-04-04
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

stone in kidney. Calculus of kidney

Interventions

Intervention 1: in the spinal group 3cc bupivacain into subarachnoid space was administerd. Intervention 2: in the general anesthesia group received 5mg/kg nesdonal and maintained with 100 microgr/kg/
Treatment - Drugs
Treatment - Other
in the spinal group 3cc bupivacain into subarachnoid space was administerd.
in the general anesthesia group received 5mg/kg nesdonal and maintained with 100 microgr/kg/min of propofol

Sponsors

Tehran University of Medical Science
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 85 Years

Inclusion criteria

Inclusion criteria: inclusion criteria:age above 18 years-kidney stone with 20-40mm-American Society of Anesthesiologists score =I exclusion ceriteria:significant comorbidity-pregnancy-severe obesity-sensitivity to local anesthetic.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Blood loss volume. Timepoint: during intervention. Method of measurement: visual estimation of blood loss in the buttle as vell as counting the bloody gauzes.;Need for transfusion. Timepoint: after intervention. Method of measurement: refer to patient file.

Secondary

MeasureTime frame
Blood pressure. Timepoint: during procedure. Method of measurement: automatic BP monitoring.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactGholamreza Movasaghi MD

Tehan University of Medical Science

gmovasaghi@yahoo.ir+98 21 8864 4411

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026